Alector (ALEC) Cash & Current Investments (2018 - 2026)
Alector's (ALEC) quarterly Cash & Current Investments came in at $172.8 million in Q2 2026, down 43.77% year-over-year from $307.3 million in Q2 2025, and down 16.33% quarter-over-quarter from $206.5 million in Q1 2026.
Analysis
Alector (ALEC) Cash & Current Investments (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash & Current Investments for 9 consecutive years, with $172.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 43.77% year-over-year to $172.8 million in Q2 2026; TTM through Jun 2026 was $172.8 million, a 43.77% decrease from a year earlier, with the FY2025 full-year figure at $256.0 million, down 38.07% from the prior year.
- Cash & Current Investments was $172.8 million for Q2 2026 at Alector, down from $206.5 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $868.6 million in Q1 2022 and troughed at $172.8 million in Q2 2026.
- A 5-year average of $506.1 million and a median of $526.1 million in 2023 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 153.11% in 2022 and sank 43.77% in 2026, its largest moves.
- Over 5 years, Cash & Current Investments stood at $712.9 million in 2022, then decreased by 23.0% to $548.9 million in 2023, then declined by 24.68% to $413.4 million in 2024, then slumped by 38.07% to $256.0 million in 2025, then sank by 32.51% to $172.8 million in 2026.
- The last three Cash & Current Investments figures came in at $172.8 million (Q2 2026), $206.5 million (Q1 2026), and $256.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 7.85 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 7.99 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 5.18 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 5.14 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 3.31 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 172.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172.80 Mn |
| Mar 31, 2026 | 206.52 Mn |
| Dec 31, 2025 | 256.02 Mn |
| Sep 30, 2025 | 291.11 Mn |
| Jun 30, 2025 | 307.28 Mn |
| Mar 31, 2025 | 354.55 Mn |
| Dec 31, 2024 | 413.40 Mn |
| Sep 30, 2024 | 457.20 Mn |
| Jun 30, 2024 | 503.33 Mn |
| Mar 31, 2024 | 562.08 Mn |
| Dec 31, 2023 | 548.86 Mn |
| Sep 30, 2023 | 588.86 Mn |
| Jun 30, 2023 | 630.05 Mn |
| Mar 31, 2023 | 669.33 Mn |
| Dec 31, 2022 | 712.85 Mn |
| Sep 30, 2022 | 758.31 Mn |
| Jun 30, 2022 | 808.86 Mn |
| Mar 31, 2022 | 868.57 Mn |
| Dec 31, 2021 | 735.25 Mn |
| Sep 30, 2021 | 777.85 Mn |